These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11041100)

  • 1. Inducible nitric oxide-mediated myocardial apoptosis contributes to graft failure during acute cardiac allograft rejection in mice.
    Takahashi W; Suzuki JI; Izawa A; Takayama K; Yamazaki S; Isobe M
    Jpn Heart J; 2000 Jul; 41(4):493-506. PubMed ID: 11041100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis.
    Szabolcs MJ; Ma N; Athan E; Zhong J; Ming M; Sciacca RR; Husemann J; Albala A; Cannon PJ
    Circulation; 2001 May; 103(20):2514-20. PubMed ID: 11369694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection.
    Mannon RB; Roberts K; Ruiz P; Laubach V; Coffman TM
    J Heart Lung Transplant; 1999 Sep; 18(9):819-27. PubMed ID: 10528743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis.
    Koglin J; Granville DJ; Glysing-Jensen T; Mudgett JS; Carthy CM; McManus BM; Russell ME
    Circulation; 1999 Feb; 99(6):836-42. PubMed ID: 9989972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection.
    Worrall NK; Misko TP; Botney MD; Sullivan PM; Hui JJ; Suau GM; Manning PT; Ferguson TB
    Ann Thorac Surg; 1999 Mar; 67(3):716-22. PubMed ID: 10215216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNI-1493 prolongs survival and reduces myocyte loss, apoptosis, and inflammation during rat cardiac allograft rejection.
    Yang X; Szabolcs M; Minanov O; Ma N; Sciacca RR; Bianchi M; Tracey KJ; Michler RE; Cannon PJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):146-55. PubMed ID: 9676735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase.
    Szabolcs M; Michler RE; Yang X; Aji W; Roy D; Athan E; Sciacca RR; Minanov OP; Cannon PJ
    Circulation; 1996 Oct; 94(7):1665-73. PubMed ID: 8840859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts.
    Cooper M; Lindholm P; Pieper G; Seibel R; Moore G; Nakanishi A; Dembny K; Komorowski R; Johnson C; Adams M; Roza A
    Transplantation; 1998 Oct; 66(7):838-44. PubMed ID: 9798691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection.
    Worrall NK; Misko TP; Sullivan PM; Hui JJ; Ferguson TB
    Ann Thorac Surg; 1996 Aug; 62(2):378-85. PubMed ID: 8694595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
    Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
    J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of COX-2 during cardiac allograft rejection.
    Yang X; Ma N; Szabolcs MJ; Zhong J; Athan E; Sciacca RR; Michler RE; Anderson GD; Wiese JF; Leahy KM; Gregory S; Cannon PJ
    Circulation; 2000 Feb; 101(4):430-8. PubMed ID: 10653836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive diagnosis of cardiac allograft rejection by detection of cytokine transcription in situ.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    Cardiovasc Res; 1998 Nov; 40(2):307-13. PubMed ID: 9893724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection.
    Worrall NK; Chang K; Suau GM; Allison WS; Misko TP; Sullivan PM; Tilton RG; Williamson JR; Ferguson TB
    Circ Res; 1996 May; 78(5):769-79. PubMed ID: 8620596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate.
    Nakanishi AL; Roza AM; Adams MB; Seibel R; Moore-Hilton G; Kalyanaraman B; Pieper GM
    Free Radic Biol Med; 1998 Jul; 25(2):201-7. PubMed ID: 9667497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model.
    Ohki S; Iizuka K; Ishikawa S; Kano M; Dobashi K; Yoshii A; Shimizu Y; Mori M; Morishita Y
    J Heart Lung Transplant; 2001 Sep; 20(9):956-63. PubMed ID: 11557190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition.
    Soto PF; Jia CX; Rabkin DG; Hart JP; Carter YM; Sardo MJ; Hsu DT; Fisher PE; Pinsky DJ; Spotnitz HM
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):39-46. PubMed ID: 10884653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.
    Szabolcs MJ; Sun J; Ma N; Albala A; Sciacca RR; Philips GB; Parkinson J; Edwards N; Cannon PJ
    Circulation; 2002 Oct; 106(18):2392-6. PubMed ID: 12403672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.